Latest Stock Market News

JM Financial has upgraded Aster DM Healthcare to a BUY rating with a revised target price of Rs 532. The brokerage highlights Aster s valuation gap compared to peers and expects synergies from the Aster-QCIL merger to drive revenue growth. They anticipate a significant improvement in EBITDA and RoIC, projecting a 34% upside for the stock.

Quess Corp shares surge by 6% after receiving NCLT approval to list its newly demerged entities, Bluspring Enterprises and Digitide Solutions. The demerger aims to enhance operational efficiency and unlock shareholder value, as Quess Corp prepares for independent growth strategies for the new firms.

Indian benchmark indices opened lower on Friday, influenced by weakness in Asian markets and declines in IT and private banking stocks. This downturn follows two sessions of gains driven by the possibility of US tariff relaxation on Canadian and Mexican goods and the recent drop in oil prices. Investors await crucial US labor market data for further direction.

Global uncertainties, including policy directions from the U.S., have had an impact, while domestic factors such as weak earnings and high valuations have added to market pressure

Power Grid received the LoI on March 6, 2025, for a project that includes enhancing transformation capacity at the Kurnool-III substation, extending the C’peta substation, and establishing a 765kV double-circuit transmission line in Andhra Pradesh.

Emkay recommends buying Vedanta, targeting Rs 575 within a year, up from Rs 435.95. Vedanta, a large cap firm in the diversified sector, reported Q3 income up by 2.21% QoQ and 9.57% YoY, with a net profit of Rs 4876 crore. Hindustan Zinc, contributing 40% to EBITDA, aims to double its capacity by 2030.

Biocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will supply the insulin, while Civica will manufacture and commercialize it, enhancing patient access to high-quality, affordable medication for diabetes management.

This presentation highlights five critical factors to help investors distinguish hidden gems from value traps

Foreign institutional investors (FIIs) have been rapidly offloading Indian equities, with February seeing notable sell-offs in sectors like capital goods, FMCG, financials, and oil & gas. Factors such as high valuations, attractive US bond yields, and Indian tax regimes are driving this exodus, significantly impacting market dynamics.

Axis Securities has an equal weight rating on HDFC Bank with a target price of Rs 2,000. HDFC Bank’s recent financials reflect a slight decline in total income, yet the bank maintains a solid net profit. Key drivers include improving NIMs, controlled costs, and strong asset quality. Risks involve potential slowdown in credit momentum and deposit mobilization challenges.